Retractable Technologies (NYSE:RVP) Coverage Initiated at StockNews.com

StockNews.com started coverage on shares of Retractable Technologies (NYSE:RVP) in a research note published on Monday. The firm issued a hold rating on the stock.

Retractable Technologies Stock Down 8.2 %

RVP stock opened at $0.63 on Monday. Retractable Technologies has a fifty-two week low of $0.62 and a fifty-two week high of $1.34. The company has a market capitalization of $19.00 million, a price-to-earnings ratio of -1.04 and a beta of 2.06. The business’s 50 day moving average price is $0.78 and its two-hundred day moving average price is $0.97. The company has a debt-to-equity ratio of 0.01, a quick ratio of 6.54 and a current ratio of 9.51.

Retractable Technologies (NYSE:RVP) last issued its quarterly earnings results on Wednesday, August 14th. The company reported ($0.48) earnings per share for the quarter. The firm had revenue of $6.03 million during the quarter. Retractable Technologies had a negative return on equity of 18.67% and a negative net margin of 46.72%.

Insider Buying and Selling

In related news, CEO Thomas J. Shaw purchased 71,422 shares of the business’s stock in a transaction that occurred on Friday, September 20th. The shares were bought at an average price of $0.82 per share, for a total transaction of $58,566.04. Following the purchase, the chief executive officer now directly owns 14,743,907 shares of the company’s stock, valued at approximately $12,090,003.74. This represents a 0.49 % increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders acquired a total of 179,649 shares of company stock worth $143,163 in the last three months. 55.00% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Retractable Technologies stock. PFG Investments LLC acquired a new stake in Retractable Technologies, Inc. (NYSE:RVP) during the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 34,600 shares of the company’s stock, valued at approximately $27,000. PFG Investments LLC owned approximately 0.12% of Retractable Technologies at the end of the most recent quarter. Institutional investors own 7.58% of the company’s stock.

Retractable Technologies Company Profile

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.